Literature DB >> 18479347

Reducing the variation in performance of antibody titrations.

J P AuBuchon1, J de Wildt-Eggen, L J Dumont.   

Abstract

BACKGROUND: Antibody titration is difficult to standardize. We investigated whether a detailed, uniform procedure for antibody titration would reduce variation in both tube-based and gel card titres in an international study.
METHODS: Laboratories (n = 35) tested proficiency testing material provided by the College of American Pathologists each according to (i) their routine method; (ii) a detailed, uniform method; and (iii) the uniform method titrating the serum sample against a red cell of specified phenotype (D+ C- c+ E+ e- for anti-D; A(1) for anti-A) instead of the red cell of the same phenotype provided in the proficiency testing kit. Uniform method results were reported with 1+ and w+ end-points. Paired statistical analyses of variance were conducted using the F-test.
RESULTS: The variance between laboratories was not significantly reduced with the uniform method using a 1+ end-point. However, a statistically significant reduction in the variance of anti-D and anti-A titres by the tube-based uniform technique after 37 degrees C incubation and conversion to the antiglobulin (AHG) phase was seen when 19 laboratories reanalysed their results using a w+ end-point. Too few laboratories reported results with a w+ end-point in gel card testing to allow analysis. Titration against red cells of the specified phenotype provided by the participating laboratory did not appear to introduce additional variance. Overall, results reported based on the gel card technique at the AHG phase (1+ end-point) showed reduced variance compared to tube-based techniques.
CONCLUSIONS: A detailed, uniform method for antibody titration at 37 degrees C and read at the AHG phase in a tube-based method with a w+ end-point reduced interlaboratory variability.

Mesh:

Substances:

Year:  2008        PMID: 18479347     DOI: 10.1111/j.1423-0410.2008.01043.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  6 in total

Review 1.  Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy.

Authors:  Maria Sassi; Umberto Maggiore; Carlo Buzio; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

2.  A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies.

Authors:  Karen Quillen; Sherry L Sheldon; Jennifer A Daniel-Johnson; A Hallie Lee-Stroka; Willy A Flegel
Journal:  Transfusion       Date:  2011-01       Impact factor: 3.157

3.  Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions.

Authors:  Jennifer Daniel-Johnson; Susan Leitman; Harvey Klein; Harvey Alter; Agnes Lee-Stroka; Phillip Scheinberg; Jeremy Pantin; Karen Quillen
Journal:  Transfusion       Date:  2009-05-11       Impact factor: 3.157

4.  Comparison of ABO antibody titers on the basis of the antibody detection method used.

Authors:  Seon Joo Kang; Young Ae Lim; Sae Yun Baik
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

5.  Standardization of ABO antibody titer measurement at laboratories in Korea.

Authors:  Young Ae Lim; Seon Joo Kang
Journal:  Ann Lab Med       Date:  2014-10-28       Impact factor: 3.464

6.  Antibody titers in Group O platelet donors.

Authors:  Anita Amar Tendulkar; Puneet Ashok Jain; Sanjay Velaye
Journal:  Asian J Transfus Sci       Date:  2017 Jan-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.